Characterizing Vascular Dysfunction in Genetically Modified Mice through the Hyperoxia Model.

Area of Science:

• Physiology
• Pathophysiology
• Biomedical Engineering

Background:

• Microcirculatory dysfunction is central to various diseases.
• Accurate models are crucial for understanding and treating microcirculatory pathophysiology.
• Current models may lack the resolution to capture subtle vascular changes.

Purpose of the Study:

• To validate a novel hyperoxia-mouse model for studying microcirculatory pathophysiology.
• To assess the model's ability to differentiate between healthy and diseased states.
• To identify key vascular components indicative of specific pathophysiological processes.

Main Methods:

• Utilized a hyperoxia-mouse model with control, diabetic (db/db), and cardiac hypertrophy (CH) groups (n=41).
• Collected perfusion data using laser Doppler flowmetry (LDF) during rest, hyperoxia, and recovery phases.
• Applied LDF wavelet transform components analysis (WA) to dissect cardiorespiratory, myogenic, endothelial, and sympathetic vascular components.

Main Results:

• The LDF WA successfully identified cardiorespiratory, myogenic, and endothelial components as key markers.
• Diabetic mice (db/db) showed significant differences in myogenic and endothelial components compared to controls.
• Increased sympathetic components were observed in both diabetic (db/db) and cardiac hypertrophy (CH) models.

Conclusions:

• The hyperoxia-mouse model is reproducible, robust, and capable of discriminating between different pathophysiological states.
• LDF WA provides a powerful tool for in-depth analysis of vascular pathophysiology.
• The model and analysis method offer valuable insights into microcirculatory dysfunction in metabolic and cardiac diseases.